Avricore Health Inc.
AVCR.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -32.98% | 0.32% | 35.26% | 50.58% | 62.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -32.98% | 0.32% | 35.26% | 50.58% | 62.61% |
| Cost of Revenue | -39.90% | -8.02% | 25.41% | 29.78% | 49.07% |
| Gross Profit | -20.74% | 14.47% | 53.95% | 103.96% | 93.74% |
| SG&A Expenses | 18.93% | 1.11% | -6.59% | -11.33% | 0.11% |
| Depreciation & Amortization | 47.37% | 25.00% | 29.41% | 102.51% | 110.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.09% | -4.27% | 11.36% | 14.34% | 28.11% |
| Operating Income | -1,157.07% | 74.79% | 130.01% | 120.44% | 107.81% |
| Income Before Tax | -24,328.57% | -156.44% | 8.83% | 110.32% | 99.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24,328.57% | -156.44% | 8.83% | 110.32% | 99.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24,328.57% | -156.44% | 8.83% | 110.32% | 99.37% |
| EBIT | -1,157.07% | 74.79% | 130.01% | 120.44% | 107.81% |
| EBITDA | -153.97% | 62.46% | 446.53% | 231.16% | 236.40% |
| EPS Basic | -- | -156.00% | 11.54% | 110.81% | 100.00% |
| Normalized Basic EPS | -2,600.00% | 68.75% | 115.63% | 108.70% | 97.62% |
| EPS Diluted | -3,025.00% | -203.45% | -25.00% | 105.41% | 94.03% |
| Normalized Diluted EPS | -2,600.00% | 68.75% | 115.63% | 108.70% | 97.62% |
| Average Basic Shares Outstanding | 1.33% | 1.03% | 0.76% | 0.68% | 0.99% |
| Average Diluted Shares Outstanding | -0.11% | 2.47% | 2.20% | 2.13% | 2.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |